Tumor Genomic Profiling denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for tumor genomic profiling are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Limits the Quantity of Tumor Genomic Profiling Tests — and How to Appeal

Tumor genomic profiling — including comprehensive genomic sequencing and large multi-gene panel tests — is subject to quantity-limit policies at Cigna that restrict how often a patient can receive such testing, either within a defined time period or within the course of treatment for a single cancer diagnosis. These limits are intended to prevent redundant testing but can create barriers when clinical circumstances genuinely justify additional or repeat profiling.

### Why This Denial Happens

Cigna's quantity-limit denials on genomic testing typically arise because the plan's records show a prior comprehensive genomic test was already approved and performed for this patient, and the policy caps coverage at one test per episode, per cancer type, or within a rolling time window. The denial assumes the prior result is still clinically actionable. This assumption breaks down in several common scenarios: disease progression to a new stage or site, histologic transformation, acquisition of a new tissue specimen from a metastatic lesion, or a change in treatment intent that requires re-profiling.

### Why It Is Appealable

A quantity-limit denial is a coverage determination, not a clinical judgment about what the patient needs. When the clinical record demonstrates a material change in circumstances since the prior test — making the prior result insufficient to guide current treatment decisions — the quantity-limit rationale is directly refutable. The appeal must focus on articulating the clinical distinction between the prior test and the current request.

### Federal Appeal Framework

• Internal appeal: Submit within the timeframe on your denial notice (typically 180 days for ACA-compliant plans). Cigna must respond within 30 days for pre-service or 60 days for post-service appeals.
• External review (ACA §2719): After an adverse internal decision, you have approximately four months to request an independent external review by an IRO. The IRO's decision is binding on Cigna.
• ERISA §503: For employer-sponsored plans, ERISA guarantees a full-and-fair review. You may request the complete administrative record, including the criteria applied and the reviewing physician's rationale.
• Expedited review: Available when delay would seriously jeopardize health; decisions are generally required within 72 hours.

### Documentation to Gather

1. Current pathology and staging documentation — records confirming the cancer's current state, including any changes (new metastatic site, histologic transformation, stage progression) since the prior test. 2. Prior test records — the original genomic test report with date, panel type, tissue source, and results, plus a clear explanation of why those results cannot answer the current clinical question. 3. Clinical event justifying re-testing — chart notes documenting the specific event (progression, new biopsy, change in treatment plan) that makes additional profiling necessary. 4. Ordering oncologist's medical-necessity letter — a signed letter explaining what the prior test showed, why it is no longer sufficient for current treatment planning, and what specific clinical question the new test will answer. 5. Applicable guideline reference — citation from the ordering oncologist of the relevant NCCN guideline or equivalent professional society recommendation supporting re-testing in this clinical scenario.

### Criteria-Mapping Structure

Download Cigna's current medical coverage policy for the specific test code at cigna.com. Identify the exact quantity-limit criteria and any stated exceptions for re-testing. Build a two-column table: policy criterion on the left, chart documentation satisfying it on the right. For the quantity-limit criterion specifically, document the clinical event that distinguishes this request from the prior test. Address each criterion individually so the reviewer cannot sustain the denial without specifying which criterion the patient fails to meet.